NCT03845062 (ESSI) is a clinical trial in Obstructive Sleep Apnea Hypopnea Syndrome, sponsored by University Hospital, Montpellier.

Who is sponsoring NCT03845062?

NCT03845062 is sponsored by University Hospital, Montpellier.

What condition does NCT03845062 study?

NCT03845062 studies Obstructive Sleep Apnea Hypopnea Syndrome.

Is NCT03845062 still recruiting?

NCT03845062 is currently completed. Last updated 19 February 2019.

Last reviewed 2019-02-19 · How we verify

NCT03845062: ESSI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Contribution of Drug Induced Sleep Endoscopy of Pediatric Obstructive Sleep Apnea Hypopnea Syndrome

Completed Last updated 19 February 2019

What this trial tests

trial in Obstructive Sleep Apnea Hypopnea Syndrome in 31 participants. Completed in 1 August 2018.

Timeline

1 October 2015

Primary endpoint
1 June 2018

1 August 2018

Quick facts

Lead sponsor	University Hospital, Montpellier
Status	Completed
Study type	OBSERVATIONAL
Enrollment	31
Start date	1 October 2015
Primary completion	1 June 2018
Estimated completion	1 August 2018
Sites	1 location across France

Conditions studied

Obstructive Sleep Apnea Hypopnea Syndrome — all drugs for Obstructive Sleep Apnea Hypopnea Syndrome →

Sponsor

University Hospital, Montpellier

Who can join

Under 12, any sex, with Obstructive Sleep Apnea Hypopnea Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The role of drug-induced sleep endoscopy (DISE) in the management of obstructive sleep apnea hypopnea syndrome (OSAHS) is not precisely defined for children. The primary objective of this study was to describe the consequences of DISE in the therapeutic management for children with OSAHS. The secondary objectives were to analyze the correlation between the number of obstructive sites found during DISE, the value of apnea-hypopnea index (AHI), and the type of OSAHS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Montpellier trials

Trials by the same sponsor.

NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03845062 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
Last refreshed: 19 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03845062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing